How did Health Canada consult with Canadians before drafting the consent to use regulations?
On October 30, 2004, Health Canada published a Notice of Intent in the Canada Gazette, Part I, advising the public and stakeholders that it planned to undertake public involvement activities and to provide interested parties the opportunity to participate in the development of components of the regulatory framework under the AHR Act. Health Canada further held public technical briefing and information sessions in St. John’s, Montreal, Toronto, Winnipeg, Saskatoon, Edmonton and Vancouver between December 2004 and January 2005. In addition, two cross-Canada teleconference calls were held for individuals unable to attend the public sessions. The main purpose of these sessions was to explain the regulatory framework set out in the Act and to outline the regulatory development process with a focus on section 8 of the AHR Act. Approximately 180 representatives of non-governmental and voluntary organizations and members of the general public attended these sessions. Technical briefings with a
